MRNA

2024Q2BMO

Moderna Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2024-08-01 · Fiscal end 2024-06-30 · Features as of 2024-07-31

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS-3.35
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move3.6%
IV front—
P/C full—
P/C front—
Features as of2024-07-31

Run-up

Close—
Ret 5d+0.9%
Ret 10d-3.9%
Ret 20d+1.8%
Ret 30d-13.5%

Post-Earnings Data

Results & reaction

Print

Actual EPS
-3.33Beat
Estimated EPS-3.35
Actual revenue
221.0M
Surprise %+0.6%
Beat / missBeat
Beat streak 43
Beat streak 83

Reaction

1-day stock reaction-5.4%
Implied vs actual

Implied 3.6%Actual 16.5%

Gap reaction-16.5%
Day result-21.0%
Next-day upNo
Realized / IV4.61×

Post tape

Post 5d-10.5%
Post 10d-8.0%
Post volume18.6M
Vol ×10d7.91×
Vol ×20d6.99×
Post range9.3%